cytosine has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez, C | 1 |
| Martínez-Calle, N | 1 |
| Martín-Subero, JI | 1 |
| Segura, V | 1 |
| Delabesse, E | 1 |
| Fernandez-Mercado, M | 1 |
| Garate, L | 1 |
| Alvarez, S | 1 |
| Rifon, J | 1 |
| Varea, S | 1 |
| Boultwood, J | 1 |
| Wainscoat, JS | 1 |
| Cruz Cigudosa, J | 1 |
| Calasanz, MJ | 1 |
| Cross, NC | 1 |
| Prósper, F | 1 |
| Agirre, X | 1 |
1 other study available for cytosine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.
Topics: 5-Methylcytosine; Computational Biology; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Protei | 2012 |